Mediware Enters Into Merger Agreement With Thoma Bravo

Shareholders to Receive $22.00 per Share in Cash; Transaction Valued at Approximately $195 Million

Mediware Information Systems, Inc. (Nasdaq:MEDW), a leading provider of clinical software solutions, today announced it has entered into a definitive merger agreement to be acquired by leading private equity investment firm Thoma Bravo, LLC in a transaction valued at approximately $195 million. Under the terms of the agreement, pending shareholder approval, Mediware shareholders will receive $22.00 in cash for each share of Mediware common stock. This represents an approximately 40 percent premium over the Company's most recent closing price.

Published: 12 September 2012
Written by Editor
Nasdaq   Healthcare   M & A   Up on News   Interesting News  
Read more: Mediware Information Systems Inc ( MEDW )

Aetna Enters into Agreement to Acquire Coventry Health Care, Inc.

 
Aetna (NYSE: AET) and Coventry Health Care, Inc. (NYSE: CVH) today announced that they have entered into a definitive agreement pursuant to which Aetna will acquire Coventry in a transaction valued at $7.3 billion, including the assumption of Coventry debt.(1) Coventry is a diversified managed health care company that offers a full portfolio of risk and fee-based products, including Medicare Advantage and Medicare Part D programs, Medicaid managed care plans, group and individual health insurance, coverage for specialty services such as workers’ compensation, and network rental services. The acquisition is projected to add nearly 4 million medical members and 1.5 million Medicare Part D members to Aetna’s membership. On a pro forma basis, the transaction increases Aetna’s share of revenues from Government business to over 30 percent from 23 percent currently.
Published: 20 August 2012
Written by Editor
NYSE   Healthcare   M & A   Up on News   Interesting News  
Read more: Coventry Health Care Inc ( CVH )

Medidata Solutions Reports Second Quarter 2012 Results

    Announces $100+ million contract for Medidata clinical cloud
    Reports record quarterly revenues of $53.5 million
    Adds record number of new customers
    Raises full year revenue guidance to between $217 and $219 million

Medidata Solutions (MDSO), a leading global provider of cloud-based drug development solutions that optimize the efficiency of clinical development, today announced its financial results for the second quarter of 2012, and provided detailed financial guidance for the third quarter and full year 2012.

Published: 31 July 2012
Written by Editor
Nasdaq   Healthcare   Financial Results   Up on News   Interesting News  
Read more: Medidata Solutions ( MDSO )

Genesis HealthCare to Acquire Sun Healthcare Group, Inc.

Sun Healthcare Group, Inc. (SUNH) today announced that it has signed a definitive agreement for the acquisition of Sun Healthcare (Sun) by Genesis HealthCare (Genesis). The combined company will be able to strengthen its core business lines and enhance its collective ability to provide the highest quality patient care while meeting the current challenges facing the healthcare industry.

Under the terms of the merger agreement, Genesis will acquire Sun for $8.50 per share of common stock in cash, resulting in a transaction value of approximately $275 million net of cash and debt acquired.

Published: 21 June 2012
Written by Editor
Nasdaq   Healthcare   M & A   Up on News   Interesting News  
Read more: Sun Healthcare Group Inc ( SUNH )

Shoppers Drug Mart Enters Into Agreement to Acquire Paragon Pharmacies

Shoppers Drug Mart Corporation (TSX:SC.TO - News) ("Shoppers" or the "Company") today announced that it has entered into a definitive agreement with Paragon Pharmacies Limited (TSXV:PGN.V - News) ("Paragon") pursuant to which Shoppers has agreed to purchase from Paragon 19 retail pharmacies and three central fill pharmacies located in British Columbia, Alberta and Manitoba for a purchase price of approximately $75 million in cash, subject to certain adjustments.  The completion of the transaction is subject to the approval of Paragon's shareholders, acceptance by the TSX Venture Exchange and certain other customary closing conditions.  The parties anticipate that the transaction will close in the third quarter of 2012.

Published: 23 May 2012
Written by Editor
TSX Venture   Healthcare   M & A   Up on News   Interesting News  
Read more: Paragon Pharmacies Ltd ( PGN )
  1. Catalyst Health Solutions ( CHSI )
  2. ZOLL Medical Corporation ( ZOLL )
  3. Transcend Services Inc ( TRCR )
  4. Sourcefire Inc ( FIRE )
  5. Complete Genomics Inc ( GNOM )